Gufic Biosciences soars 14%, hits 52-week high on improved business outlook

Rating agency CRISIL Ratings has revised the company's outlook on the long-term bank facilities

Shares of Gufic Biosciences (Gufic) hit a 52-week high of Rs 283.50 after they rallied 14 per cent on the BSE in Tuesday's intra-day trade on the back of heavy volumes on improved business outlook.

At 09:51 AM, the stock was trading 11 per cent higher at Rs 274.75, as compared to 0.70 per cent decline in the S&P BSE Sensex. Trading volumes on the counter jumped over five-fold with a combined 2.01 million equity shares having changed hands on the NSE and BSE till the time of writing of this report.

Gufic, on Monday, announced that it